REFERENCES
- García de Lomas J, TorreHas A, García Rodríguez JA, Baquero F. A national, multicenter, and prospective survey of respiratory bacteria susceptibility to 12 commonly used antimi-crobials in Spain. In: Program and Abstracts of the Thirty-sev-enth Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, American Society for Microbiology, Washington, DC. 1997: Abstract E-102, p. 132.
- Garau J, Aguilar L, Rodríguez-Creixems M, et al. Influence of comorbidity and severity on the clinical outcome of bacteremic pneumococcal pneumonia treated with I3-lactam monotherapy. J Chemother 1999; 11: 266–272.
- Pallarés R, Liñares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneu-mococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333: 474–480.
- Balcabao IP, Aguilar L, Martin M, Garcia Y, Dal-Re R, Prieto J. Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: In vitro pharmacodynamic simulation. Antimicrob Agents Chemother 1996; 40: 2904–2906.
- Soriano F, Ponte C, Nieto E, Parra A. Correlation of “in vitro” activity and pharmacokinetic parameters with “in vivo” effect of amoxicillin, co-amoxiclav and cefotaxime in an experimental pneumonia with Streptococcus pneumoniae in mice. J Antimicrob Chemother 1996; 38: 227–236.
- Aguilar L, Rosendo J, Balcabao IP, et al. Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumo-coccal strains: a phase I study. Antimicrob Agents Chemother 1997; 41: 1389–1391.
- National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacte-ria that grow aerobically - Third Edition: Approved Standard M7-A3. NCCLS Villanova, Pa., 1993.
- Prieto J, Giménez MJ, Balcabao IP, Gornez-Lus ML, Aguilar L. Does the degree of penicillin susceptibility of Streptococcus pneumoniae affect the bactericidal activity of co-amoxiclav versus oral cephalosporins at physiological con-centrations? An in vitro pharmacodynamic simulation. J Chemother 1999; 11 (5): 345–348.
- Amsterdam D. Assessing cidal activity of antimicrobial agents: problems and pitfalls. The Antimicrob Newslett 1990; 7: 49–56.